NCT02184039View on ClinicalTrials.gov

Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases

CompletedOBSERVATIONAL
Enrollment

12,687

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

July 31, 2004

Conditions
Osteoarthritis
Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184039 - Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases | Biotech Hunter | Biotech Hunter